Diego Anazco, MD

545 posts

Diego Anazco, MD banner
Diego Anazco, MD

Diego Anazco, MD

@danazcomd

PGY-2 @UTSWInternalMed | Research Collaborator @MayoClinicGIHep | MD @USFQ_Ecuador 🇪🇨 | Aspiring GI | #COYG 🔴 | ⚽️ 🏓🧉🤿

Katılım Temmuz 2012
707 Takip Edilen758 Takipçiler
Diego Anazco, MD retweetledi
Arsenal
Arsenal@Arsenal·
Arsenal: 2025/26 Premier League champions.
Français
3.1K
56.8K
196.3K
3.6M
Diego Anazco, MD retweetledi
Arsenal
Arsenal@Arsenal·
The Arsenal. Your Premier League champions.
Arsenal tweet media
English
27.7K
196.5K
572.7K
31.6M
Diego Anazco, MD
Diego Anazco, MD@danazcomd·
Don’t miss this great opportunity! Excited for the upcoming “Coffee with the Expert” session with @JaimeAlmandoz If you’re interested in obesity medicine, research, or academic mentorship, this is a session you won’t want to miss! ☕️ @ObesitySociety @UTSWInternalMed
The Obesity Society@ObesitySociety

☕ Join @JaimeAlmandoz, MD, MBA, for Coffee with the Expert on May 28, 2-3 pm ET! 🔗 Register: ow.ly/GXiA50YYvBP #ObesityScience #ObesityMedicine #Mentorship #EarlyCareer #TheObesitySociety @UTSWMedCenter

English
0
1
8
870
Diego Anazco, MD retweetledi
Texas Liver Care (TLC)
Texas Liver Care (TLC)@TexasLiverCare·
Another excellent #DDW2026 Great connecting with colleagues, collaborators & industry partners on advancing liver & metabolic health, expanding clinical trial access, & improving patient care Thanks to all who took the time to meet with @TexasLiverCare & @EvidentisHQ in Chicago
Texas Liver Care (TLC) tweet mediaTexas Liver Care (TLC) tweet mediaTexas Liver Care (TLC) tweet mediaTexas Liver Care (TLC) tweet media
English
1
6
16
709
Diego Anazco, MD retweetledi
Ariel Aday
Ariel Aday@ArielAday·
Proud to showcase the incredible work from @UTSWGI at @DDWMeeting! 🔥 📍 50+ lectures & posters 🎤 📊 📍 Faculty, fellows, and trainees leading innovation in GI 🧠 Join us in Chicago and follow along as we share advances in hepatology, IBD, GI oncology, and beyond 💫
Ariel Aday tweet media
English
1
4
46
1.9K
Diego Anazco, MD retweetledi
University of Toronto
GLP-1 medicine improves liver health independent of weight loss, according to a new study #UofT ➡️ uoft.me/cjP
University of Toronto tweet media
English
0
22
104
7K
Diego Anazco, MD retweetledi
AASLD
AASLD@AASLDtweets·
As the role of #GLP1 therapies in #MASLD continues to grow, clinicians need clear guidance. A new Practice Guidance update in @HEP_Journal provides evidence-based recommendations on using semaglutide therapy for MASH, including patient selection, comorbidity management, and monitoring strategies. 📗 View the update: bit.ly/4s4QM6A
AASLD tweet media
English
1
28
64
3.9K
Diego Anazco, MD retweetledi
NEJM
NEJM@NEJM·
The IARC Working Group summarizes guidance on 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 screen-and-treat programs for gastric cancer prevention and concludes that prevention is the most effective strategy amid a rising global burden. Learn more: nejm.org/doi/full/10.10…
NEJM tweet media
English
2
36
100
15.3K
Daniela Dominguez
Daniela Dominguez@DaniDominguez99·
Please pinch me because it still does not feel real! First picture: March 8, 2024. My first time ever at University Hospitals before my acting internship. Second picture: Class of 2030 @CwruNeuro?!!! A future neurologist at my dream program! Please follow the 🧵🪡
Daniela Dominguez tweet mediaDaniela Dominguez tweet media
English
5
4
158
7K
George Doumat
George Doumat@GeorgeDoumatMD·
I’m excited to be staying on as Chief Resident in Internal Medicine for the 2027-2028 academic year. Thankful for the opportunity to keep working with an outstanding group of residents and faculty. @UTSWInternalMed
George Doumat tweet media
Dallas, TX 🇺🇸 English
6
2
82
6.2K
Diego Anazco, MD retweetledi
Texas Liver Care (TLC)
Texas Liver Care (TLC)@TexasLiverCare·
Great start to our St. Patrick’s Day Liver & Metabolic Health Fair ☘️ 20 community members already screened and we’re just getting started, 3 hours still to go. Come by Texas Liver Care in Fort Worth to check your liver and metabolic health! Along with plenty of activities for kids!
English
0
8
12
725
Diego Anazco, MD retweetledi
JAMA Network Open
JAMA Network Open@JAMANetworkOpen·
Among adults with overweight or obesity, <25% remained on a #GLP1RA at 12 months. Switching agents was common and linked to higher persistence and adherence than remaining on one agent. ja.ma/40oLmqU
JAMA Network Open tweet media
English
1
2
19
5.5K